ILMN: Illumina to Announce Fourth Quarter and Fiscal Year 2014 Financial Results on Tuesday, January 27, 2015


(BUSINESS WIRE)–Jan. 13, 2015– Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for fourth quarter and fiscal year 2014 following the close of market on Tuesday, January 27, 2015. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Jay Flatley, Chief Executive Officer, Francis deSouza, President, and Marc Stapley, Senior Vice President and Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results. Conference Call Details The conference call will begin at 2:00 p… Read more

Shares of Illumina closed yesterday at $190.1 . ILMN has a 1-year high of $199.48 and a 1-year low of $113.15. The stock’s 50-day moving average is $188.06 and it’s 200-day moving average is $177.27.

On the ratings front, Illumina has been the subject of a number of recent research reports. In a report published on January 6, analyst Tycho Peterson from J.P. Morgan assigned a Buy rating to ILMN, with a price target of $270, which represents a potential upside of 42.0% from where the stock is currently trading. Separately, on November 28, Wedbush`s Zarak Khurshid maintained a Buy rating on Illumina shares and has a price target of $200.

In total,2 research analysts have assigned a Hold rating and 3 research analysts have given a Buy rating to the stock. When considering if perhaps the stock is under or overvalued, the average price target is $190.1 which is 6.6% above where the stock closed yesterday.

Illumina, Inc., is developer, manufacturer and marketer of integrated systems for the large scale analysis of genetic variation and biological function.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts